Company Filing History:
1 out of 164 
1 out of 2 Years Active: 2011-2018
Title: Rastislav Tamaskovic: A Pioneer in Cancer Therapy Innovations
Introduction: Rastislav Tamaskovic, an accomplished inventor based in Rheinfelden, Switzerland, has made significant contributions to the fields of oncology and molecular biology. With a total of two patents to his name, his innovative work focuses on advancing cancer therapies through novel therapeutic agents.
Latest Patents: Tamaskovic's most recent patents include groundbreaking inventions aimed at improving cancer treatment options. The first patent, titled "Bispecific HER2 ligands for cancer therapy," describes a bispecific HER2-targeting agent. This invention comprises a first polypeptide ligand that binds to HER2 extracellular domain 1, a second polypeptide ligand that binds to HER2 extracellular domain 4, and a linker that covalently attaches the two polypeptide ligands. This dual-targeting approach holds promise for enhancing the efficacy of cancer therapies. His second patent relates to the "Phosphorylated Ndr kinase," which pertains to the phosphorylated form of nuclear serine/threonine protein kinase, specifically the nuclear Dbf2-related kinase (Ndr). This invention facilitates the development of assays and materials designed to identify modulators of this crucial kinase, with applications spanning molecular biology, chemistry, pharmacology, and screening technologies.
Career Highlights: Throughout his career, Rastislav Tamaskovic has been associated with prominent institutions known for their contributions to biomedical research. He has worked at the University of Zurich and the Novartis Research Foundation, where he applied his expertise to advance innovative therapeutic solutions.
Collaborations: Rastislav has collaborated with respected colleagues, including Martin Schwill and Andreas Pluckthun. These collaborations have further enriched his work, contributing to the development of his innovative inventions and enhancing the potential impact on cancer therapy.
Conclusion: Rastislav Tamaskovic stands out as a pioneering inventor whose work is poised to make a lasting impact on cancer treatment. Through his notable patents and collaborations, he continues to drive innovation in the field, helping to pave the way for new therapies and improving patient outcomes in oncology. His dedication to research and development showcases the importance of ingenuity in addressing complex medical challenges.